The Last Lecture meets The Bright Hour in this inspirational account of how Zulema Arroyo Farley lives an inspiring life, refusing to let a rare form of cancer determine her destiny.
Now available in Spanish.
On her fourth date with her now husband, Zulema and Nick put together a bucket list of experiences they wanted to share with one another throughout their years together. Based on their hopes, dreams, and fantasies, the list featured a variety of adventurous and decadent tasks, from learning to skydive to riding the fastest rollercoaster in the world. Wildly successful in her career, married to the man of her dreams, and living on her own terms, Zulema was living a fairy tale. But, two years into her marriage, her bucket list took on a shocking urgency.
She is diagnosed with a rare, incurable cancer called sarcoma, which only amounts to 1% of adult cancers and 20% of childhood cancers. Today, Zulema’s cancer is in remission, but it’s not a question of if her tumor will return, but when. Faced with this new reality, Zulema joined forces with her husband, tapped into their art aficionado network, and founded Artz Cure Sarcoma to raise research funds and awareness and serve as a support network for others with sarcoma. Despite excruciating pain, setbacks, and personal struggles, Zulema is determined to not leave a second of life unexperienced and to inspire others to do the same.
Zulema Arroyo Farley was an accomplished advertising and marketing senior executive, known for revitalizing numerous Fortune 500 brands. She is the founder, board chairman, and president of Artz Cure Sarcoma Foundation, an organization created with her husband to raise awareness and research funds to find treatment options for sarcoma. Following her diagnosis in 2015, Zulema has worked relentlessly to raise awareness for sarcoma around the world, and was named one of People en Español’s 25 Most Powerful Women in September 2016 for her efforts. She currently resides in Manhattan with her husband and continues to fight an on-going battle against sarcoma.